Kelsen DP - Search Results

1

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.

Casper ES, Green MR, Kelsen DP, Heelan RT, Brown TD, Flombaum CD, Trochanowski B, Tarassoff PG. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1994;12(1):29-34. doi: 10.1007/BF00873232. Invest New Drugs. 1994. PMID: 7960602 Clinical Trial.

2

Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).

Casper ES, Kelsen DP, Alcock NW, Young CW. Casper ES, et al. Among authors: kelsen dp. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2023-5. Cancer Treat Rep. 1979. PMID: 575066 No abstract available.

3

Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.

Casper ES, Gralla RJ, Kelsen DP, Cvitkovic E, Golbey RB. Casper ES, et al. Among authors: kelsen dp. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2107-9. Cancer Treat Rep. 1979. PMID: 575068 No abstract available.

4

A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.

Kelsen D, Martin DS, Colofiore J, Sawyer R, Coit D. Kelsen D, et al. Cancer. 1992 Oct 1;70(7):1988-92. doi: 10.1002/1097-0142(19921001)70:7<1988::aid-cncr2820700730>3.0.co;2-k. Cancer. 1992. PMID: 1381991 Clinical Trial.

5

Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.

Casper ES, Schwartz GK, Kelsen DP. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Aug;10(3):205-9. doi: 10.1007/BF00877247. Invest New Drugs. 1992. PMID: 1385354 Clinical Trial.

6

Menogaril in the treatment of malignant mesothelioma: a phase II study.

Hudis CA, Kelsen DP. Hudis CA, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Jul;10(2):103-6. doi: 10.1007/BF00873126. Invest New Drugs. 1992. PMID: 1386842 Clinical Trial.

7

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.

Casper ES, Schwartz GK, Johnson B, Kelsen DP. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Nov;10(4):313-6. doi: 10.1007/BF00944187. Invest New Drugs. 1992. PMID: 1487406 Clinical Trial.

8

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M. Kelsen D, et al. J Clin Oncol. 1992 Apr;10(4):541-8. doi: 10.1200/JCO.1992.10.4.541. J Clin Oncol. 1992. PMID: 1548519 Clinical Trial.

9

Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kelsen dp. J Clin Oncol. 1992 Aug;10(8):1218-24. doi: 10.1200/JCO.1992.10.8.1218. J Clin Oncol. 1992. PMID: 1634912 Clinical Trial.

10

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.

Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, Bains M, Burt M, Heelan R, Hilaris B. Kelsen DP, et al. J Clin Oncol. 1990 Aug;8(8):1352-61. doi: 10.1200/JCO.1990.8.8.1352. J Clin Oncol. 1990. PMID: 1696309 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters